X

Legal Notices

Disclaimer

ADVERTISING MATERIAL
The material contained on this Web site is provided for informational purposes only and does not constitute legal advice. The publication and receipt of any information contained on this Web site does not create an attorney-client relationship with Barash Law LLC or with any of our attorneys. Readers should not act upon any information on this site without seeking professional legal counsel. While the information on this Web site is maintained and periodically updated for accuracy, this information may contain omissions or errors for which we disclaim any and all liability.

Privacy Statement

Barash Law LLC does not collect identifying information from visitors to its Web site unless the information is provided by the visitor or the visitor's internet browser. We will only respond to direct inquiries, and will use information collected from internet browsers for the sole purpose of monitoring Web site usage. We do not share Web site data with outside third-parties. Barash Law LLC is not responsible for the privacy practices or content of any links to other Web sites contained in our Firm’s Web site. 

If you have any questions or concerns regarding this Privacy Statement, please contact us at info@ebarashlaw.com

Moving in the Right Direction: Cocrystals and the FDA

Read More

Using Solid Form Patents to Protect Pharmaceutical Products — Part I

Read More

Using Solid Form Patents to Protect Pharmaceutical Products — Part II

Read More

NEWS & EVENTS

EVENTS
AIPLA CLE Webinar:
Solid Form IP -Reinvigorating Composition of Matter.
August 24, 2021
12:30-2:00PM
Drug repositioning traditionally deploys new formulations or methods of treatment to protect the repositioned intellectual property estate.  However, there are circumstances where it is possible to get an additional composition of matter patent for the repositioned asset, namely, by using a solid form patent strategy.  This article discusses the theory and practice behind using solid form patents to start a new composition of matter clock and how this strategy has been deployed in practice.
AIPLA Website
EVENTS
IP WATCHDOG LIVE:
Surviving and Thriving in IP Due Diligence in Life Science Transactions
September 13th, 2021
2:00PM CT
Renaissance dallas richardson, dallas tx
Eyal Barash will be a participant in a panel discussion that will take attendees through the due diligence process through the eyes of a small to medium sized pharmaceutical company interested in making a transaction with its' intellectual property. For conference information and registration details, click the link below.
More Information

QUESTIONS ANSWERED

What is a solid form?

A solid form is the solid representation of a chemical compound.  Examples include polymorphs, salts, solvates, hydrates, cocrystals, and amorphous solids.

Read More
Why patent solid forms?

Solid forms are compositions of matter and Orange-Book listable as drug substance.  When the science is right, patenting follows.

Read More
How do you patent a solid form?

The same rules apply to solid forms as to any other inventions.  Careful attention should be paid to the kinds and quality of data used in solid form patents.

Read More

WHAT WE DO

pharmaceutical patents

Orange-Book Listable Patents Add Value

deals


Intellectual Property as Deal Currency

ip strategy and execution

A Strategy Requires a Realistic Plan

in-house
counsel

Legal Functionality as a Business Driver
© 2016 Barash Law LLC
Contact Us
Legal Notices